Trial Profile
A Phase I Single Dose Pharmacokinetic Study of DG17 versus DG17 in combination with Ritonavir in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs DG 17 (Primary) ; Ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Narhex Australia Pty Ltd
- 17 Jun 2016 New trial record